Annual ROE
-56.29%
-0.93%-1.68%
December 31, 2023
Summary
- As of February 10, 2025, DCPH annual return on equity is -56.29%, with the most recent change of -0.93% (-1.68%) on December 31, 2023.
- During the last 3 years, DCPH annual ROE has fallen by -7.40% (-15.14%).
Performance
DCPH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-50.29%
+0.51%+1.00%
March 1, 2024
Summary
- As of February 10, 2025, DCPH quarterly return on equity is -50.29%, with the most recent change of +0.51% (+1.00%) on March 1, 2024.
- Over the past year, DCPH quarterly ROE has dropped by -0.41% (-0.82%).
Performance
DCPH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DCPH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.7% | -0.8% |
| 3 y3 years | -15.1% | -0.8% |
| 5 y5 years | -57.9% | -0.8% |
DCPH ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +1.7% | +25.6% | +5.6% | +48.9% |
| 5 y | 5-year | +21.0% | +25.6% | +14.7% | +48.9% |
| alltime | all time | -403.3% | +25.6% | -139.9% | +190.3% |
Deciphera Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | -50.29%(-1.0%) |
| Dec 2023 | -56.29%(+1.7%) | -50.80%(+1.8%) |
| Sep 2023 | - | -49.88%(+4.7%) |
| Jun 2023 | - | -47.62%(-3.9%) |
| Mar 2023 | - | -49.57%(-6.0%) |
| Dec 2022 | -55.36%(-21.7%) | -52.73%(-17.3%) |
| Sep 2022 | - | -63.78%(-10.6%) |
| Jun 2022 | - | -71.38%(-4.7%) |
| Mar 2022 | - | -74.89%(+8.8%) |
| Dec 2021 | -70.71%(+44.6%) | -68.85%(+22.6%) |
| Sep 2021 | - | -56.14%(+16.6%) |
| Jun 2021 | - | -48.13%(+9.8%) |
| Mar 2021 | - | -43.85%(-2.9%) |
| Dec 2020 | -48.89% | -45.15%(+0.4%) |
| Sep 2020 | - | -44.97%(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -49.40%(+3.8%) |
| Mar 2020 | - | -47.59%(-0.1%) |
| Dec 2019 | -46.53%(+30.5%) | -47.62%(+2.0%) |
| Sep 2019 | - | -46.67%(-2.2%) |
| Jun 2019 | - | -47.74%(+10.1%) |
| Mar 2019 | - | -43.37%(+17.8%) |
| Dec 2018 | -35.66%(+30.5%) | -36.81%(+4.1%) |
| Sep 2018 | - | -35.37%(-39.7%) |
| Jun 2018 | - | -58.70%(-38.6%) |
| Mar 2018 | - | -95.56%(-34.6%) |
| Dec 2017 | -27.33%(-247.3%) | -146.01%(-375.6%) |
| Sep 2017 | - | 52.98%(-58.0%) |
| Jun 2017 | - | 126.14%(+688.4%) |
| Mar 2017 | - | 16.00%(+52.5%) |
| Dec 2016 | 18.56%(+8.0%) | 10.49% |
| Dec 2015 | 17.19% | - |
FAQ
- What is Deciphera Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals annual ROE year-on-year change?
- What is Deciphera Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals quarterly ROE year-on-year change?
What is Deciphera Pharmaceuticals annual return on equity?
The current annual ROE of DCPH is -56.29%
What is the all time high annual ROE for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high annual return on equity is 18.56%
What is Deciphera Pharmaceuticals annual ROE year-on-year change?
Over the past year, DCPH annual return on equity has changed by -0.93% (-1.68%)
What is Deciphera Pharmaceuticals quarterly return on equity?
The current quarterly ROE of DCPH is -50.29%
What is the all time high quarterly ROE for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high quarterly return on equity is 126.14%
What is Deciphera Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, DCPH quarterly return on equity has changed by -0.41% (-0.82%)